More From Other Websites
CASI Pharmaceuticals Receives Approval From CFDA To Conduct Phase II Clinical Trial With ENMD-2076... Jul 21 2014
EntreMed Stockholders Approve Name Change To CASI Pharmaceuticals Jun 13 2014
EntreMed appoints Franklin C. Salisbury, Jr., President of NFCR, to Board of Directors Jun 03 2014
ENTREMED INC Financials May 23 2014
EntreMed Announces Poster Presentations At ASCO On ENMD-2076 May 19 2014
EntreMed Reports First Quarter 2014 Financial Results May 15 2014
EntreMed Reports 2013 Fourth Quarter And Full Year Financial Results Mar 21 2014
EntreMed Reports 2013 Fourth Quarter And Full Year Financial Results Mar 21 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Purcelm2
ReplyPurcelm2 - 3 months ago
1
Gurufocus
ReplyGurufocus - 1 year ago
test
Donli
ReplyDonli - 1 year ago
test 38
Gurufocus
ReplyGurufocus - 1 year ago
test37
Gurufocus
ReplyGurufocus - 1 year ago
test 36
Donli
ReplyDonli - 1 year ago
test 24
Donli
ReplyDonli - 1 year ago
test 23
Rommy
ReplyRommy - 1 year ago
How do I create portfolio using GureFocus?


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK